EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Lipoprotein(a): A Novel Risk Factor for Heart Failure and Biomarker of Prognosis? From Pathophysiology to Clinical Practice

Anna Kowalczys iD, Joanna Marlęga-Linert iD, Marcin Gruchała iD, Agnieszka Mickiewicz iD

Cardiac Failure Review · 20.04.2026

DOI: 10.15420/cfr.2025.46 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiac Failure Review, online erschienen am 20.04.2026. Verfasst von Anna Kowalczys und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Cardiology, Medical University of Gdańsk Gdańsk, Poland. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is one of the most difficult challenges in cardiology nowadays, constituting a significant global epidemiological, social and economic burden. For many years, there has been a search for new risk factors that predispose to the development of HF and biomarkers that could indicate HF patients with a poorer prognosis. Lipoprotein(a) (Lp[a]) is an estimated risk factor for atherosclerotic cardiovascular disease and aortic valve stenosis, but its causal role in HF has not been clearly defined yet. The results of the few studies regarding the influence of elevated Lp(a) on the development and course of HF are uncertain. However, most authors suggest that elevated Lp(a) increases the risk of HF and may correlate with a higher risk of major adverse cardiovascular events. The aim of this review is to present the current state of knowledge on the importance of the association between Lp(a) levels and HF, from pathophysiology to clinical practice including current management.

Schlagwörter

Stichwörter der Autor:innen

Lipoprotein(a)biomarkercardiovascular diseaseheart failureprognosis

Autor:innen und Institutionen

  • 1st Department of Cardiology, Medical University of Gdańsk Gdańsk, Poland.

ORCID-Profile: Anna Kowalczys, Joanna Marlęga-Linert, Marcin Gruchała, Agnieszka Mickiewicz

Zitieren

APA

Kowalczys, A., Marlęga-Linert, J., Gruchała, M., & Mickiewicz, A. (2026). Lipoprotein(a): A Novel Risk Factor for Heart Failure and Biomarker of Prognosis? From Pathophysiology to Clinical Practice. Cardiac Failure Review. https://doi.org/10.15420/cfr.2025.46

Vancouver

Kowalczys A, Marlęga-Linert J, Gruchała M, Mickiewicz A. Lipoprotein(a): A Novel Risk Factor for Heart Failure and Biomarker of Prognosis? From Pathophysiology to Clinical Practice. Cardiac Failure Review. 2026. doi:10.15420/cfr.2025.46

BibTeX
@article{Kowalczys2026,
  author = {Kowalczys, Anna and Marlęga-Linert, Joanna and Gruchała, Marcin and Mickiewicz, Agnieszka},
  title = {Lipoprotein(a): A Novel Risk Factor for Heart Failure and Biomarker of Prognosis? From Pathophysiology to Clinical Practice},
  journal = {Cardiac Failure Review},
  year = {2026},
  doi = {10.15420/cfr.2025.46}
}
Kostenlos starten →